Montreal-based healthcare agency Lally McFarland & Pantello/Euro RSCG Canada has recently picked up several new and expanded assignments.

Abbot Pharmaceutical Products Division has given the agency responsibility for Norvir, a protease inhibitor for the treatment of hiv infection and aids.

For Schering Canada, a new client, the agency is working on Nasonex, a nasal steroid for allergic rhinitis.

At the Toronto office, the agency has added Zeneca’s Arimidex, an aromatase inhibitor used for postmenopausal breast cancer, to its portfolio.